CFTR-Inhibitor-II 10mg 10mg | Purity Not Available
Adooq Bioscience
CFTR inhibitor II, also known as GlyH-101, is a glycine hydrazide that selectively and reversibly blocks the CFTR channel (Ki = 4.3 uM).
More Information Supplier PageCFTR inhibitor II, also known as GlyH-101, is a glycine hydrazide that selectively and reversibly blocks the CFTR channel (Ki = 4.3 uM).
More Information Supplier PageDeltarasin is a novel small molecule inhibiting the KRAS PDE?? interaction and thus impairing oncogenic KRAS signalling.
More Information Supplier PageDeltarasin is a novel small molecule inhibiting the KRAS PDE?? interaction and thus impairing oncogenic KRAS signalling.
More Information Supplier PageDeltarasin is a novel small molecule inhibiting the KRAS PDE?? interaction and thus impairing oncogenic KRAS signalling.
More Information Supplier PageDeltarasin is a novel small molecule inhibiting the KRAS PDE?? interaction and thus impairing oncogenic KRAS signalling.
More Information Supplier PageTG003 is a potent, specific, reversible, and ATP competitive inhibitor of Cdc2 like kinase(Clk).-
More Information Supplier PageTAPI-0 is an inhibitor of TACE (IC50 = 50-100 nM) as well as other matrix and membrane metalloproteases
More Information Supplier PageTAPI-0 is an inhibitor of TACE (IC50 = 50-100 nM) as well as other matrix and membrane metalloproteases
More Information Supplier PageTAPI-0 is an inhibitor of TACE (IC50 = 50-100 nM) as well as other matrix and membrane metalloproteases
More Information Supplier PageAWD 131-138 is a new low-affinity partial benzodiazepine receptor agonist with potent anticonvulsant and anxiolytic properties in rodent models.
More Information Supplier Page